Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival

Clinical Cancer Research

Volumn 11, Issue 18, 2005, Pages 6574-6581

  Weichert, Wilko ^a   Denkert, Carsten ^a   Burkhardt, Mick ^a   Gansukh, Tserenchunt ^a   Bellach, Joachim ^a   Altevogt, Peter ^b   Dietel, Manfred ^a   Kristiansen, Glen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CELL ADHESION MOLECULE;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE MARKER; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD24; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 25144503826     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0606     Document Type: Article

References (29)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999;79:191-203.
3. Kristiansen G, Denkert C, Schluns K, et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 2002;161:1215-21.
4. Kristiansen G, Pilarsky C, Pervan J, et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 2004;58:183-92.
5. Kristiansen G, Schluns K, Yongwei Y, et al. CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 2003;88:231-6.
6. Kristiansen G, Winzer KJ, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003;9:4906-13.
7. Darwish NS, Kim MA, Chang MS, et al. Prognostic Significance of CD24 Expression in Gastric Carcinoma. Cancer ResTreat 2004;5:298-302.
8. Pirruccello SJ, LeBien TW. The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol 1986;136:3779-84.
9. Fischer GF, Majdic O, Gadd S, Knapp W. Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol 1990;144:638-41.
10. Akashi T, Shirasawa T, Hirokawa K. Gene expression of CD24 core polypeptide molecule in normal rat tissues and human tumor cell lines. Virchows Arch 1994;425:399-406.
11. Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 2004;35:255-62.
12. Aigner S, Ruppert M, Hubbe M, et al. Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol 1995;7:1557-65.
13. Aigner S, Sthoeger ZM, Fogel M, et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 1997;89:3385-95.
14. Sammar M, Aigner S, Hubbe M, et al. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol 1994;6:1027-36.
15. Aigner S, Ramos CL, Hafezi-Moghadam A, et al. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 1998;12:1241-51.
16. Nestl A, Von Stein OD, Zatloukal K, et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001;61:1569-77.
17. Saito A, Fujii G, Sato Y, et al. Detection of genes expressed in primary colon cancers by in situ hybridisation: overexpression of RACK 1. Mol Pathol 2002;55:34-9.
18. Pichlmaier H, Hossfeld DK, Sauer R. Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon und Rektumkarzinom vom 11.03.1994. Chirurg 1994;65:411-2.
19. Cram DS, McIntosh A, Oxbrow L, Johnston AM, DeAizpurua HJ. Differential mRNA display analysis of two related but functionally distinct rat insulinoma (RIN) cell lines: identification of CD24 and its expression in the developing pancreas. Differentiation 1999;64:237-46.
20. Shirasawa T, Akashi T, Sakamoto K, et al. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues. Dev Dyn 1993;198:1-13.
21. Figarella-Branger D, Moreau H, Pellissier JF, Bianco N, Rougon G. CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathol (Berl) 1993;86:275-84.
22. Redondo P, Garcia-Foncillas J, Okroujnov I, de Felipe I, Quintanilla E. CD24 expression on human keratinocytes. Exp Dermatol 1998;7:175-8.
23. Droz D, Zachar D, Charbit L, et al. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol 1990;137:895-905.
24. Chappel MS, Hough MR, Mittel A, et al. Cross-linking the murine heat-stable antigen induces apoptosis in B cell precursors and suppresses the anti-CD40-induced proliferation of mature resting B lymphocytes. J Exp Med 1996;184:1638-49.
25. Suzuki T, Kiyokawa N, Taguchi T, et al. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol 2001;166:5567-77.
26. Jacob J, Bellach J, Grutzmann R, et al. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 2004;4:454-60.
27. Choi YL, Kim SH, Shin YK, et al. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol Oncol 2005;97:379-86.
28. Sirnons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-72.
29. Jacobson K, Dietrich C. Looking at lipid rafts? Trends Cell Biol 1999;9:87-91.